Key Documents

View All Documentation

468916

[3S-(3α,4aβ,8aβ)]-N-(tert-Butyl)decahydro-3-isoquinolinecarboxamide

Name: [3S-(3α,4aβ,8aβ)]-N-(tert-Butyl)decahydro-3-isoquinolinecarboxamide
Brand: ALDRICH

98%

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₄H₂₆N₂O

CAS Number:

136465-81-1

Molecular Weight:

238.37

NACRES:

NA.22

PubChem Substance ID:

24870541

UNSPSC Code:

12352005

MDL number:

MFCD01313226

Assay:

98%

Form:

solid

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

assay

98%

form

solid

optical activity

[α]22/D −71°, c = 1 in methanol

mp

112-115 °C (lit.)

SMILES string

CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1

InChI

1S/C14H26N2O/c1-14(2,3)16-13(17)12-8-10-6-4-5-7-11(10)9-15-12/h10-12,15H,4-9H2,1-3H3,(H,16,17)/t10-,11+,12-/m0/s1

InChI key

UPZBXVBPICTBDP-TUAOUCFPSA-N

Description

Application

Fragment present in various HIV-1 protease inhibitors currently in clinical trials for AIDS treatment.

pictograms

GHS05,GHS07

signalword

Danger

hcodes

H302,H318,H412

pcodes

P273 - P280 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

08606CH

03027ME

09611TQ

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Trova, M.P. et al.

Bioorganic & Medicinal Chemistry Letters, 3, 1595-1595 (1993)

A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.

T J Tucker et al.

Journal of medicinal chemistry, 35(14), 2525-2533 (1992-07-20)

A series of HIV-1 protease inhibitors containing a novel hydroxyethyl secondary amine transition state isostere has been synthesized. The compounds exhibit a strong preference for the (R) stereochemistry at the transition state hydroxyl group. Molecular modeling studies with the prototype

Global Trade Item Number

SKU	GTIN
468916-1G	04061826129401